Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02106611 · ClinicalTrials.gov registry record
Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 133
- Enrollment target
NCT02106611: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02106611 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 133 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02106611 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
Study Summary
This study will test whether cardiac MRI can improve early detection of Hodgkin lymphoma associated heart disease compared to a stress echocardiogram. By doing both stress echocardiography and cardiac MRI, we will compare the ability of the two tests to detect heart disease.
Interventions
- OTHER Clinical Assessment
- PROCEDURE Stress cardiac MRI
- PROCEDURE Stress echocardiogram
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2014-04 |
| Est. Completion | 2026-02-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02106611
The ClinicalTrials.gov registry entry for NCT02106611 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Clinical Assessment is the first listed.
NCT02106611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02106611 about?
NCT02106611 is a clinical study titled "Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors". This study will test whether cardiac MRI can improve early detection of Hodgkin lymphoma associated heart disease compared to a stress echocardiogram. By doing both stress echocardiography and cardiac MRI, we will compare the ability of the two tests to detect heart disease.
What is the current status of trial NCT02106611?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2014-04. Estimated completion is 2026-02-06.
What interventions are being tested in trial NCT02106611?
The interventions under investigation include: Clinical Assessment (OTHER), Stress cardiac MRI (PROCEDURE), Stress echocardiogram (PROCEDURE).
Who is sponsoring clinical trial NCT02106611?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.